Ebos in $700 Million Takeover to Grow Australian Drugs Business

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Ebos Group Ltd. will become the largest pharmaceutical wholesaler in Australia and New Zealand after agreeing a NZ$865 million ($700 million) takeover of Australia’s Symbion Ltd.

Ebos will raise NZ$367 million in cash and issue NZ$498 million of shares to The Zuellig Group Inc., which owns Symbion, the Christchurch-based company said in a statement. Ebos shares are halted while an institutional share placement to raise NZ$90 million is conducted, while a 7-for-20 rights offer is also proposed.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC